EOHILIA™ (budesonide oral suspension) is an FDA approved 12-week oral treatment for EoE in people 11 years and older. It has not been shown to be safe and effective for longer than 12 …

Patient access info for EOHILIA™ (budesonide oral suspension) treatment. Website for U.S. Healthcare Professionals. See Important Safety Information and Full Prescribing Information.

Mar 17, 2025 · Historic EoE Treatments Eohilia is the first FDA-approved medication specifically designed for the treatment of EoE. It is an oral suspension of budesonide, a corticosteroid that …

UnitedHealthcare Pharmacy Clinical Pharmacy Programs ... Background: Eohilia (budesonide oral suspension)* is a corticosteroid indicated for 12 weeks of treatment in adult and pediatric …

Sep 1, 2025 · Overview Eohilia (budesonide) oral suspension is a corticosteroid indicated for 12 weeks of treatment in adult and pediatric patients 11 years of age and older with eosinophilic …

EOHILIA (budesonide oral suspension) is a 12-week oral treatment used to treat EoE in people 11 years and older. It has not been shown to be safe and effective for longer than 12 weeks. …

What is EOHILIA? EOHILIA is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older.

The EOHILIA Patient Support and Copay Program The EOHILIA Patient Support and Copay Program is designed to help guide you along your EoE treatment journey. Commercially …

Learn how EOHILIA™ (budesonide oral suspension) works for eosinophilic esophagitis (EoE) treatment and how to take it. See Important Safety Information and Prescribing Information.

Learn about EOHILIA™ (budesonide oral suspension), including efficacy, safety, dosing, and patient support. Website for U.S. Healthcare Professionals. See Important Safety Information …